Randomized phase 2 trial and open-label extension of domagrozumab in Duchenne muscular dystrophy

1 ntroduction

Source: Neuromuscular Disorders - May 17, 2020 Category: Neurology Authors: Kathryn R. Wagner, Hoda Z. Abdel-Hamid, Jean K. Mah, Craig Campbell, Michela Guglieri, Francesco Muntoni, Yasuhiro Takeshima, Craig M. McDonald, Anna Kostera-Pruszczyk, Peter Karachunski, Russell J. Butterfield, Eugenio Mercuri, Chiara Fiorillo, Enrico S. Source Type: research